CN1872144B - Drop pills of kudzuvine root, and preparation method - Google Patents
Drop pills of kudzuvine root, and preparation method Download PDFInfo
- Publication number
- CN1872144B CN1872144B CN2005100136322A CN200510013632A CN1872144B CN 1872144 B CN1872144 B CN 1872144B CN 2005100136322 A CN2005100136322 A CN 2005100136322A CN 200510013632 A CN200510013632 A CN 200510013632A CN 1872144 B CN1872144 B CN 1872144B
- Authority
- CN
- China
- Prior art keywords
- adjuvant
- drop
- filler
- kudzuvine root
- drop pill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006187 pill Substances 0.000 title claims abstract description 218
- 235000010575 Pueraria lobata Nutrition 0.000 title claims description 46
- 244000046146 Pueraria lobata Species 0.000 title claims description 45
- 238000002360 preparation method Methods 0.000 title claims description 42
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000002671 adjuvant Substances 0.000 claims description 91
- 239000000203 mixture Substances 0.000 claims description 83
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 74
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 74
- 229920002472 Starch Polymers 0.000 claims description 44
- 239000008107 starch Substances 0.000 claims description 44
- 235000019698 starch Nutrition 0.000 claims description 44
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 41
- 239000000758 substrate Substances 0.000 claims description 41
- 239000008101 lactose Substances 0.000 claims description 34
- 229920002545 silicone oil Polymers 0.000 claims description 28
- 238000010438 heat treatment Methods 0.000 claims description 26
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 24
- 229930003944 flavone Natural products 0.000 claims description 24
- 150000002212 flavone derivatives Chemical class 0.000 claims description 24
- 235000011949 flavones Nutrition 0.000 claims description 24
- 229940057995 liquid paraffin Drugs 0.000 claims description 24
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000945 filler Substances 0.000 claims description 22
- 238000002844 melting Methods 0.000 claims description 21
- 230000008018 melting Effects 0.000 claims description 21
- 235000010489 acacia gum Nutrition 0.000 claims description 19
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 16
- 241000196324 Embryophyta Species 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 239000002826 coolant Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 9
- 229920002101 Chitin Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- 244000286663 Ficus elastica Species 0.000 claims description 4
- 244000275012 Sesbania cannabina Species 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims 14
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 5
- 241000219780 Pueraria Species 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 69
- 239000012530 fluid Substances 0.000 description 55
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 44
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 43
- 239000000811 xylitol Substances 0.000 description 43
- 235000010447 xylitol Nutrition 0.000 description 43
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 43
- 229960002675 xylitol Drugs 0.000 description 43
- 238000003756 stirring Methods 0.000 description 39
- 238000001035 drying Methods 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 230000004927 fusion Effects 0.000 description 27
- 239000012188 paraffin wax Substances 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 229940079593 drug Drugs 0.000 description 19
- 238000009413 insulation Methods 0.000 description 19
- 238000009472 formulation Methods 0.000 description 15
- 210000000214 mouth Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000003350 kerosene Substances 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 5
- 229960000935 dehydrated alcohol Drugs 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229960004756 ethanol Drugs 0.000 description 5
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- -1 hydroxypropyl Chemical group 0.000 description 4
- 239000006225 natural substrate Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 229940032147 starch Drugs 0.000 description 4
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229940090044 injection Drugs 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- 235000010439 isomalt Nutrition 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229960001947 tripalmitin Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000219781 Pueraria montana var. lobata Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A dripping pill of pueraria root and its preparing process are disclosed. It has high natural level and safety and low toxic by-effect.
Description
Technical field
What the present invention relates to is that the natural plants active ingredient prepares novel form and preparation method thereof, and particularly, relating to the kudzu vine root is drop pill of feedstock production and preparation method thereof.
Background technology
Puerarin is to extract and isolated a kind of monomer from the dried root of legume pueraria lobata, belongs to isoflavonoid, and its Chinese name is a puerarin, English Puerarin by name, different name: puerarin, chemical name are 4 ', 7 '-dihydroxy, 8-β-D glucose isoflavone.Puerarin has the beta receptor retardation; can improve the heart, brain blood circulation, reduce myocardial oxygen consumption, antiplatelet aggregation; protection vascular endothelial cell and the effect of removing free radical have excellent curative to the ischemic heart, cerebrovascular disease and retina arteriovenous occlusive disease.The puerarin preparation that utilizes prior art to obtain has conventional oral formulations and injection etc.Owing to reasons such as technologies of preparing, exist that dissolve scattered time limit is long, dissolution is low, absorption is relatively poor after most of oral formulations are taken, problem such as liver sausage first pass effect and bioavailability are lower, thereby influence the performance of drug effect, also directly affect the effect of treatment.Though injection has the advantage that absorbs fast and instant effect, it is easy to generate anaphylaxis or untoward reaction.For example puerarin glucose injection, puerarin sodium chloride injection etc., injection exists the shortcoming of patient's medication inconvenience when curative effect can be affirmed.At present the solid preparation of puerarin has tablet, but because the dissolubility of puerarin is bad, thus tablet exist as problem such as absorbing slowly, bioavailability is little.
Drop pill is a kind of spheric pill that utilizes the solid dispersion technology system of dripping to form, and it utilizes water-solubility carrier to improve the dissolubility and the dissolution rate of medicine, improves the infiltration rate and the absorbtivity of medicine, thereby improves bioavailability, improves the curative effect of medicine.Application number is 02117473.3, and the applying date is 2002.5.20, and denomination of invention is the patent document of dropping pill of pueraria flavone and method for making thereof; Application number is 02155198.7, and the applying date is 2002.12.19, and denomination of invention is: the patent documentation of puerarin dropping pill formulation and preparation method thereof; Application number is 200310122493.8, the applying date is 2003.12.26, denomination of invention is: the patent documentation of puerarin drop pill and preparation method thereof provides the method for preparing drop pill with puerarin or Radix Puerariae flavone, the drop pill of making has overcome the existing defective of present common kudzu vine root preparation treatment cardiovascular medicament, but in this patent documentation, the substrate adjuvant that the preparation dripping pill selected is used is chemical products, and natural degree is not high.
The synthetic chemical substance commonly used as modern medicine spreaded all over each corner of human lives, chemical synthetic drug becomes the main flow of medicine, yet, appearance along with multiple difficult serious symptom miscellaneous diseases, western medical treatment presents imperfect, the human lives and the healthy reality and the up-to-date successes achieved in research have all proposed query to this situation, particularly along with the continuous appearance of chemical drugs toxic and side effects, the change of spectrum of disease and conversion of medical, make modern medicine be subjected to unprecedented challenge, and people also place hope in the application and development of traditional medicine on gradually.Advocate back to nature, pay attention to plant amedica use, hanker after traditional remedies, the trend of advocating natural drug forms, making full use of natural materials is human best selections.
At present, in the world, natural drug all has certain market, along with people increasing and the aging of population to the health requirements level of understanding, sub-health stateization, people thirst for back to nature more, the problem of utilize the high Drug therapy of pure natural degree, preventing some chemical synthetic drugs cann't be solved, so the background that exceeds its original traditional national culture has been expanded in the application of natural plant.From natural drug, seek the little and inexpensive medicine of side effect and become the target that countries in the world pharmaceutical manufacturer is chased.The European Community has carried out unified legislation to medical herbs, state medical herbs status such as Canada and Australia have legalized, U.S. government has also drafted the plant amedica management method, the compound recipe mix preparation that begins to accept natural drug is as curative, and these provide good international environment for Chinese medicine enters international medical market as curative.On the other hand, along with the quickening of global economic integration progress, particularly China becomes a full member of WTO, and Chinese Medicine market incorporates the breadth and depth of international medical big market and will further aggravate.Face the enormous impact of Asian countries's traditional medicine product such as the keen competition of powerful transnational medical group and Japan, Korea S, India, Thailand and European countries' plant amedica such as Germany, France, numerous products that China's Chinese medicine produces are owing to still can not meet the standard of international medical market and requirement and being kept outside of the door.
Expansion and human back to nature requirement along with the market global range, use the low medicine of toxic and side effects, especially pure natural medical more and more becomes people's first-selection, dropping pill formulation is a kind of efficient, quick-acting new medicine preparations that have, it has overcome the shortcoming and deficiency of Chinese medicine preparation in the past, but present dropping pill formulation generally faces following problem:
1, drop pill adjuvant pure natural degree is not high: at present, drop pill substrate adjuvant mostly is synthetic, natural degree is lower, the searching of the alternative substrate adjuvant that searching, the particularly natural degree of new alternative substrate adjuvant is high and preparation technology thereof determine, it is again very difficult thing, because the required preparation condition of at present common possible natural substrates adjuvant succedaneum is very harsh, it all is to influence the key that drop pill prepares molding that adjuvant temperature and drop pill thereof drip the system condition.The too high then viscosity of adjuvant melt temperature is low, and poor plasticity is though the adjuvant melt temperature is crossed lowplastcity by force, but drop pill has shortcomings such as easily sticking ball, distortion, therefore, seek pure natural degree height, and the adjuvant that is suitable for substituting existing drop pill substrate is a very job of hardships.
2, the drop pill outlet encounters problems: along with expanding economy, more and more internationalize in market, China is also just making great efforts to adapt to this trend, present Chinese medicine dripping pills preparation as health food, successful export to many countries, but also face many problems at present, because different countries is different to the approval of the selected adjuvant of Chinese medicine dropping pill formulation, especially industrial flourishing Europe, more strict to food adjuvant and medical auxiliary materials, and as the selected chemosynthesis adjuvant (as Polyethylene Glycol) of the dropping pill formulation of health food outlet not in the catalogue of some national food additive, it is very unfavorable that this moves towards the international market to the Chinese medicine dropping pill formulation, becomes the stumbling-block that Chinese medicine enters the international market, therefore, seek the new of one or more, can be particularly important, also very urgent for the substrate adjuvant that the international market is accepted.
3, the shortcoming of mouthfeel and onset speed: the mouthfeel of Chinese medicine and preparation thereof is relatively poor to be the big characteristics of one, people when taking some drugs to the frightened of disagreeable taste that medicine had even be better than fear far away to disease, What is more, some patients are because can not overcome the poor taste of Chinese medicine or its preparation or abnormal smells from the patient and abandon the treatment of Chinese medicine, though can improve mouthfeel as medicine being made capsule or sugar coated tablet, reducing stimulates, but disintegration rate prolongs, be unfavorable for the rapid onset of medicine, to some disease, particularly need the disease of the rapid onset of medicine inapplicable.
4, the preparation process difficulty of drop pill suitability for industrialized production: in the replacement process of dropping pill formulation adjuvant, determining of the preparation process of its suitability for industrialized production is very difficult something, as the ratio of the melt temperature of substrate adjuvant, the proportioning of dripping system temperature, adjuvant and medicine, dropper bore, condensing agent etc. all are the factors that influence drop pill, therefore, the replacement of substrate and to be suitable for suitability for industrialized production be a job consuming time, as to expend substantial contribution.
In order to change drop pill substrate adjuvant for a long time based on the situation of chemosynthesis adjuvant, it is low to solve the pure natural degree that present drop pill substrate faced, and can not satisfy more and more that people require back to nature, take low toxicity, the problem of the pure natural medical that has no side effect; Also can solve some problems that Chinese medicine preparation, particularly dropping pill formulation are run in exit procedure, strengthen the competitiveness of international market; The present invention has invented the pure Chinese medicine dripping pills preparation that a kind of toxic and side effects is low, evident in efficacy, moderate, adapt to industrialized great production by a large amount of tests and the research of preparation process.
Summary of the invention
The medicine that the purpose of this invention is to provide a kind of treatment cardiovascular and cerebrovascular vessel with new type natural substrate adjuvant preparation.
Another object of the present invention provides a kind of preparation method for the treatment of the medicine of cardiovascular and cerebrovascular vessel.
It is resulting by a large amount of tests inventing selected substrate adjuvant, it is little to have molecular weight, soluble in water, and molten diffusing speed is faster, pure natural degree height, toxic and side effects is lower, and can reduce the medicine irritation abnormal smells from the patient, has the oral cavity of improvement acid-base value during the buccal of oral cavity, improve the characteristics of oral cavity smell, the used substrate adjuvant of the present invention is the agent of food sedan-chair flavor, takes that mouthfeel is good, the acceptant characteristics of patient, is the direction of following substrate adjuvant development.
Medicine of the present invention is made of following component: puerarin or Radix Puerariae flavone, adjuvant are made, wherein adjuvant comprises filler and plasticity substrate, filler adjuvant wherein is selected from the natural adjuvant of following one or more plant origins: sorbitol, xylitol, lactose, maltose, and they contain the water of crystallization chemical compound; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: pregelatinized Starch, carboxymethyl starch, methylcellulose, sodium carboxymethyl cellulose, hydroxypropyl emthylcellulose, arabic gum, alginic acid, dextrin, cyclodextrin, agar, lactose.
In the preferred medicine of the present invention, the filler adjuvant is selected from following one or more the natural adjuvant of plant origin: xylitol, lactose; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: starch, arabic gum.
In the best medicine of the present invention, the filler adjuvant is xylitol and starch, and xylitol is 1: 0.2～1: 0.3 with the ratio of the weight of starch; Or for being lactose and starch, lactose is 1: 0.2～1: 0.3 with the ratio of the weight of starch; Or be xylitol and arabic gum, the ratio of the weight of xylitol and arabic gum is 1: 0.2～1: 0.4.
The weight proportion of mesostroma adjuvant of the present invention and puerarin or Radix Puerariae flavone is 1: 0.1～1: 1; Preferred substrate adjuvant is 1: 0.1～1: 0.6 with the ratio of the weight of puerarin or Radix Puerariae flavone; Best substrate adjuvant is 1: 0.2～1: 0.4 with the ratio of the weight of puerarin or Radix Puerariae flavone.
Can also also have erythritol in the above-mentioned adjuvant, fructose, D-ribonic acid-gamma lactone, arabitol, trehalose, D-ribose, low melting-point agarose, Lac, Raffinose, glucose, malic acid, citric acid, isomalt, dextran, chitin, sesbania gum, carrageenan, Ficus elastica, Furcellaran, the tragakanta, carrageenin, tamarind gum, pectin, xanthan gum, modified starch, hydroxypropyl starch, methylcellulose, microcrystalline Cellulose, cross-linking sodium carboxymethyl cellulose, hydroxyethylmethyl-cellulose, hydroxyethyl-cellulose, hydroxypropyl cellulose etc.
Can also contain chemosynthesis adjuvant and animal origin adjuvant in the above-mentioned adjuvant, wherein filler comprises phenylglycol, hexadecanol, octadecanol, sodium stearate, tristerin, tripalmitin, carbamide, polyoxyethylene monostearate, polyoxyethylene alkyl ether; Wherein plasticity substrate comprises polyvinylpyrrolidone, crospolyvinylpyrrolidone, carbomer, polyvinyl alcohol, acrylic resin, poloxamer, gelatin.
From reduce medicine side effect and the angle of people's generic request back to nature, the substrate adjuvant of the best of the present invention is xylitol and starch, xylitol is 1: 0.2～1: 0.3 with the ratio of the weight of starch; Or be lactose and starch, lactose is 1: 0.2～1: 0.3 with the ratio of the weight of starch; Or be xylitol and arabic gum, the ratio of the weight of xylitol and arabic gum is 1: 0.2～1: 0.4.
Medicine of the present invention can adopt the preparation of Chinese medicine preparation conventional method.The preparation of effective ingredient of the present invention can be adopted following method: water extraction, decoction and alcohol sedimentation technique, extraction, infusion process, percolation, reflux extraction, continuous backflow extraction method, macroreticular resin absorbing method preparation.For example, these crude drug pulverize mix homogeneously can be made powder takes after mixing it with water; Also can be with these medicines decocting together, the condensed water decocting liquid is made oral liquid then; But, preferably adopt following technology to extract, but this can not limit protection scope of the present invention to raw material in order to make each crude drug of this medicine better bring into play drug effect.
The preparation method of medicine of the present invention is as follows:
In appropriate amount of auxiliary materials, add puerarin or Radix Puerariae flavone, fully mix, mixture is at 45～115 ℃ of heating and meltings, stir, mixing time is 1～120 minute, insulation, at 45～95 ℃ of temperature following system, dropper bore is 1.0～4.0 millimeters, splash in-20～25 ℃ liquid paraffin, methyl-silicone oil or the vegetable oil, make drop pill, promptly.
The preparation method of preferred medicine of the present invention is as follows:
In appropriate amount of auxiliary materials, add puerarin or Radix Puerariae flavone, fully mix, mixture is at 60～85 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, insulation, at 64 ℃ of temperature following system, dropper bore is 1.1～3.5 millimeters, splash in 0～18 ℃ the liquid paraffin, methyl-silicone oil, make drop pill, promptly.
The preparation method of best medicine of the present invention is as follows:
Add puerarin or Radix Puerariae flavone in appropriate amount of auxiliary materials, fully mix, mixture stirs at 64 ℃ of heating and meltings, mixing time is 10～30 minutes, and insulation is 1.2～2.5 millimeters at 64 ℃ of temperature following system, dropper bore, splash in 0 ℃ the methyl-silicone oil, make drop pill, promptly.
More than form when producing and to increase or to reduce according to corresponding ratio, as large-scale production can be unit with kilogram or with the ton, small-scale production can be unit with the gram also, and weight can increase or reduce, but the crude drug material weight proportion constant rate between each composition.
Medicine of the present invention can be determined usage and dosage according to patient's situation in use, but every day 1-3 time, and each crude drug consumption was as the criterion with the state-promulgated pharmacopoeia dosage in every month, was no more than the pharmacopeia ormal weight.
The drop pill that the present invention is prepared, conventional drop pill advantage is simple as preparing except having, steady quality, can make liquid medicine solidification, convenient drug administration, efficient, quick-acting, its biggest advantage is:
1, the selected adjuvant pure natural of the present invention degree height: the substrate adjuvant that employed substrate adjuvant derives from natural plants or originates based on natural plants among the present invention, selected substrate adjuvant is xylitol and starch or lactose and starch or xylitol and arabic gum, this substrate adjuvant has pure natural degree height, toxic and side effects is low, mouthfeel is good, dissolve scattered time limit is short, rapid-action, it is a kind of new medium adjuvant, can be used for substituting present chemosynthesis adjuvant, the drop pill made from this kind adjuvant, it is low to solve the pure natural degree that present drop pill substrate faced, and more and more can not satisfy people and require back to nature, take low toxicity, the problem of the pure natural medical that has no side effect.
2, some problems in the outlet of solution Chinese medicine: medicine of the present invention also can solve Chinese medicine preparation, some problems of in exit procedure, being run into of dropping pill formulation particularly, solve because different countries, especially the European countries of industry prosperity are to the difference identification of the selected adjuvant of Chinese medicine dropping pill formulation, overcome as the selected adjuvant Polyethylene Glycol of the dropping pill formulation of the health food outlet defective in some national food additive catalogue not, improve the Chinese medicine dripping pills preparation and move towards the international market, strengthen the competitiveness of international market.
3, solve the relatively poor problem of dropping pill formulation taste and further improve drug effect speed (dissolve scattered time limit): the medicinal dropping ball made from this kind substrate adjuvant of the present invention, can improve Chinese medicine preparation, the particularly present not good shortcoming of dropping pill formulation taste, improve mouthfeel, more easy for patients to accept, and the drop pill that adopts the selected adjuvant of medicine of the present invention to make has shorter dissolve scattered time limit, makes drug effect faster.
4, higher safety and solve some problems in the drop pill storage process: the selected substrate of the present invention is not only additive, nutrient commonly used in the food industry, and can do medicinal, but do not see that it uses as the drug matrices adjuvant, therefore, with regard to substrate, be perfectly safe, have no side effect, a large amount of evidences, the drop pill made from this adjuvant can reduce effective ingredient separating out in storage process, the sticking ball of drop pill, easy shortcomings such as moisture absorption deliquescing, but the big production of suitability for industrialized.
In order to understand the present invention better, dissolve scattered time limit, drop pill soft durometer, the drop pill with drop pills of kudzuvine root glues test explanation advantages of the present invention such as ball below.
Test example 1: dissolve scattered time limit contrast experiment example
In vitro tests
The drop pills of kudzuvine root of making according to the new substrate drop pills of kudzuvine root of the present invention (newly) of embodiment 1 method preparation and the drop pills of kudzuvine root preparation method embodiment one that provides for 02155198.7 patent document according to application number (old) compares, by indexs such as mensuration dissolve scattered time limits, investigate its good releasing effect.
1. test medication: the new substrate drop pills of kudzuvine root of the present invention (newly); With polyethylene glycol 6000 etc. is the drop pills of kudzuvine root (old) that adjuvant is made.
2. method and result:
Dissolve scattered time limit: by " method is measured result such as table 1 under this item of Chinese pharmacopoeia.
Three batches of drop pills of kudzuvine root made from the new medium adjuvant of table 1 (newly) with the polyethylene glycol 6000 be drop pills of kudzuvine root (old) dissolve scattered time limit made of adjuvant, weight differential relatively
Test data shows, the dissolve scattered time limit of new substrate drop pills of kudzuvine root is lacking of the drop pills of kudzuvine root made of adjuvant with the Polyethylene Glycol, and the ball method of double differences of the drop pills of kudzuvine root that new, old substrate is made is different all to be controlled in the pharmacopeia prescribed limit.Result of the test explanation, the molten diffusing speed of the drop pills of kudzuvine root made from novel adjuvant is faster, is more conducive to medicine and plays a role in the shortest time; The ball method of double differences of new substrate drop pill different to be that the drop pills of kudzuvine root made of adjuvant is similar with the Polyethylene Glycol, the ball method of double differences is different all to be controlled in the pharmacopeia prescribed limit, the difference not statistically significant illustrates the alternative present chemosynthesis adjuvant of this natural substrates adjuvant, but suitability for industrialized production.
Test example 2: the new substrate drop pills of kudzuvine root of the present invention (newly) be that drop pills of kudzuvine root (old) soft durometer, the drop pill that adjuvant is made glues the ball comparative observation with the polyethylene glycol 6000
According to the new substrate drop pills of kudzuvine root of the present invention (newly) of embodiment 1 method preparation and according to application number is 02155198.7,3 batches of the drop pills of kudzuvine root (old) made of the drop pills of kudzuvine root preparation method embodiment one that provides of patent document, be loaded in the porcelain vase respectively, and use the bottle stopper good seal.Putting it into the bottom has in the exsiccator of saturated Nacl (humidity 75%) solution, exsiccator is put into 40 ℃ of drying baker of constant temperature again, and timing sampling is observed situations such as drop pill soft durometer, the sticking ball of drop pill, the results are shown in Table 2.1, table 2.2.
Three batches in table 2.1 is that the drop pills of kudzuvine root reserved sample observing that adjuvant is made compares with the polyethylene glycol 6000
Table 2.2: three batches of drop pills of kudzuvine root made from the new medium adjuvant (newly) with the polyethylene glycol 6000 be drop pills of kudzuvine root (old) character observation made of adjuvant relatively
Test data shows, new substrate drop pills of kudzuvine root soft durometer changes and be that the drop pills of kudzuvine root made of adjuvant is similar, strong slightly with the Polyethylene Glycol; The sticking ball variation of the drop pill of new substrate drop pill, firmness change and be that the drop pills of kudzuvine root made of adjuvant is similar with the Polyethylene Glycol.The result of the test explanation, the sticking ball of the drop pills of kudzuvine root that new and old substrate adjuvant is made changes, firmness change is similar, and the alternative present chemosynthesis adjuvant of this natural substrates adjuvant is described, but suitability for industrialized production.
The specific embodiment
Below in conjunction with embodiment the present invention is done step explanation, following each embodiment only is used to the present invention is described and is not limitation of the present invention.
Embodiment one
Get the 21.25g xylitol and mix, add puerarin 7.5g, fully mix with 4.25g starch, mixture is at 64 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, insulation, at 64 ℃ of temperature following system, dropper bore is 1.2～2.5 millimeters, splash in 0 ℃ the methyl-silicone oil, make 1000, to the greatest extent and wipe liquid coolant the drop pill drop that forms, back packing to be dried, promptly.
Embodiment two
Get puerarin or Radix Puerariae flavone 6.5g, lactose 19.6g, starch 5.9g are standby;
In lactose and the mixed compound of starch, add above-mentioned Radix Puerariae flavone, fully mix, mixture is at 64 ℃ of heating and meltings, stir, mixing time is 10～30 minutes, puts in the surge drum of drop pill machine insulation, in following system of 64 ℃ of temperature, surge drum water dropper gauge inner-diameter is 1.2 millimeters, and external diameter is 4.0 millimeters, and adjusting a distance is 8cm, the speed of dripping with 30 droplets/minute at the uniform velocity splashes in 0 ℃ the methyl-silicone oil, make 1000, liquid coolant is use up and wiped to the drop pill drop that forms, back packing to be dried, make drop pill, promptly.
Embodiment three
Get the mixture of xylitol 18.2g and arabic gum 7.3g, add puerarin 5.5g, mixture is put in the surge drum of drop pill machine at 60～85 ℃ of heating and meltings, and system is dripped in 60～66 ℃ of insulations, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 25cm is 20 ± 2 ℃, and the temperature of bottom 35cm is 2 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment four
It is standby to get Radix Puerariae flavone 4.5g, xylitol 21.3, starch 4.2, tragakanta 1.5g, tween 80 1.0g;
It is evenly mixed to get xylitol, starch, tragakanta and tween 80, adds above-mentioned puerarin or Radix Puerariae flavone, fully mixes, mixture stirs at 64 ℃ of heating and meltings, and mixing time is 10～30 minutes, insulation, in 64 ℃ of temperature following system, water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.0 millimeters, splashes in 0 ℃ the methyl-silicone oil, make 1000, liquid coolant is use up and wiped to the drop pill drop that forms, back packing to be dried, promptly.
Embodiment five
(a): get puerarin 20g, lactose 18.5g, chitin 2.0g is standby;
(b): in lactose and chitin, add above-mentioned puerarin or Radix Puerariae flavone, fully mix, mixture stirs at 64 ℃ of heating and meltings, mixing time is 10～30 minutes, insulation is 1.2～2.5 millimeters at 64 ℃ of temperature following system, dropper bore, splashes in 0 ℃ the methyl-silicone oil, make 1000, liquid coolant is use up and wiped to the drop pill drop that forms, back packing to be dried, promptly.
Embodiment six
Get sorbitol 25.5, Furcellaran 5.5g, heat fused adds puerarin 8g, fully stirs and makes its complete fusion, is uniformly dispersed, and puts in the surge drum of drop pill machine, and 95 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.5 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 10cm is 10 ± 2 ℃, and the temperature of bottom 40cm is-5 ± 1 ℃) in the liquid Paraffin condensed fluid with 45 droplets/minute the speed of dripping apart from being 15cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment seven
Get lactose 10.3g, carboxymethyl starch 3.1g, Lac 1.5g, heat fused adds puerarin 2g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 105 ℃ are incubated 40 minutes, and surge drum water dropper gauge inner-diameter is 2.5 millimeters, and external diameter is 4.5 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 40cm is 45 ± 2 ℃, and the temperature of bottom 35cm is 5 ± 1 ℃) in the liquid Paraffin condensed fluid with 40 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment eight
Get isomalt 5.0g, xylitol 40.g, methylcellulose 2.5g, heat fused adds puerarin 25g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 85 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.0 millimeters, and external diameter is 2.6 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 45cm is 25 ± 2 ℃, and the temperature of bottom 40cm is-8 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 3cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make drop pill, promptly.
Embodiment nine
Get puerarin 3.5g, add the 15ml dehydrated alcohol, after the slight fever dissolving, add in 20.2g lactose, the 5.5g erythritol fused solution, mix, volatilize ethanol, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment ten
Get puerarin 6.5g, add the 15m1 dehydrated alcohol, after the slight fever dissolving, add in 35.0g Raffinose, the arabic gum 1.5g fused solution, mix, volatilize ethanol, put in the surge drum of drop pill machine, 72 ℃ are incubated 40 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 7cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 11
Get tripalmitin 7.5g, xylitol 20.5g heat fused adds Radix Puerariae flavone 0.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 12
Get xylitol 20.4g, starch 6.1g and mix, heat fused adds puerarin 7g, fully stirs and makes its complete fusion, is uniformly dispersed, and puts in the surge drum of drop pill machine, and 75 ℃ are incubated 40 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 8cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 13
Get the mixture of xylitol 17.5g, starch 3.5g, heat fused adds puerarin 8g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 110 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 45 ± 2 ℃, and the temperature of bottom 35cm is 3 ± 1 ℃) in the liquid Paraffin condensed fluid with 20 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 14
Get xylitol 28g, starch 7g and mix, heat fused adds puerarin 11.5g, fully stirs and makes its complete fusion, is uniformly dispersed, and puts in the surge drum of drop pill machine, and 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 35cm is 1 ± 1 ℃) in the liquid Paraffin condensed fluid with 35 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 15
Get the mixture of xylitol 38.6g and starch 3.9g, heat fused adds puerarin 10.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 2.0 millimeters, and external diameter is 4.5 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 15cm is 10 ± 2 ℃, and the temperature of bottom 30cm is-3 ± 1 ℃) in the liquid Paraffin condensed fluid with 40 droplets/minute the speed of dripping apart from being 15cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 16
Get the mixture of xylitol 9.4g and starch 5.6g, heat fused adds puerarin 10.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 85 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.0 millimeters, and external diameter is 2.6 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 25 ± 2 ℃, and the temperature of bottom 35cm is-8 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 3cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 17
Get puerarin 7.5g, add the 15ml dehydrated alcohol, after the slight fever dissolving, add the mixture of xylitol 17g and starch 8.5g, mix, volatilize ethanol, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 18
Get the mixture of 12.25g lactose and 12.25g starch, mix the post-heating fusing, heat fused, add puerarin 8.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 99 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 19
Get the mixture of 28.5g lactose and 6g sesbania gum, mix the post-heating fusing, heat fused adds puerarin 6.6g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 35cm is 1 ± 1 ℃) in the liquid Paraffin condensed fluid with 35 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 20
Get the mixture of lactose 20.3g, Ficus elastica 3.5g, tragakanta 2.4g, mix the post-heating fusing, heat fused, add puerarin 12.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 85 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.0 millimeters, and external diameter is 2.6 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 30cm is 25 ± 2 ℃, and the temperature of bottom 35cm is-8 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 2cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 21
Get the mixture of 15.7g lactose and 7.05 Furcellaran, mix the post-heating fusing, heat fused adds puerarin 15g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the liquid Paraffin condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 22
Get the mixture of 24g xylitol and 11g chitin, mix the post-heating fusing, heat fused adds puerarin 20g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 40cm is 1 ± 1 ℃) in the liquid Paraffin condensed fluid with 35 droplets/minute the speed of dripping apart from being 10cm, collect drop pill, drop is clean, puts the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 23
Get the mixture of 14.5g xylitol and 10.5g starch, heat fused adds puerarin 9.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the methyl-silicone oil condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the methyl-silicone oil on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 24
Get the mixture of 18g lactose and 8.5g xanthan gum, heat fused adds puerarin 3.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.3 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 25cm is 20 ± 2 ℃, and the temperature of bottom 35cm is 0 ± 1 ℃) in the methyl-silicone oil condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the methyl-silicone oil on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 25
Get the mixture of 21.5g xylitol and 8.5g arabic gum, heat fused adds puerarin 4g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 60 is 1 ± 1 ℃) in the methyl-silicone oil condensed fluid with 30 minutes the speed of dripping apart from being 10, collect drop pill, drop is clean, puts the methyl-silicone oil on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 26
Get puerarin 5.5g, add the 15ml dehydrated alcohol, after the slight fever dissolving, the ratio that adds 25.5g, weight is in the mixture fused solution of 1: 0.2～1: 0.4 xylitol and arabic gum, mixes, and volatilizes ethanol, put in the surge drum of drop pill machine, 90 ℃ are incubated 40 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the methyl-silicone oil condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the methyl-silicone oil on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 27
The ratio of getting 25.5g, weight is 1: 0.2～1: 0.4 the xylitol and the mixture of arabic gum, heat fused, add puerarin 5.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the kerosene condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the kerosene on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 28
The ratio of getting 26.5g, weight is 1: 0.2～1: 0.4 the xylitol and the mixture of arabic gum, heat fused, add puerarin 12.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 95 ℃ are incubated 30 minutes, surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the kerosene condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the kerosene on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 29
Get the mixture of 20.0g xylitol and 10.0g arabic gum, heat fused adds puerarin 10.5g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 80 ℃ are incubated 20 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 35cm is 40 ± 2 ℃, and the temperature of bottom 35cm is 1 ± 1 ℃) in the kerosene condensed fluid with 35 minutes the speed of dripping apart from being 10, collect drop pill, drop is clean, puts the kerosene on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 30
Get puerarin 0.5g, add the 15ml dehydrated alcohol, after the slight fever dissolving, add in the mixture fused solution of 15.5g xylitol and 9g arabic gum, mix, volatilize ethanol, put in the surge drum of drop pill machine, 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.7 millimeters, and external diameter is 3.3 millimeters.Adjust and drip, at the uniform velocity splash into (temperature of condensed fluid top 20cm is 20 ± 2 ℃, and the temperature of bottom 30cm is 0 ± 1 ℃) in the vegetable oil condensed fluid with 30 droplets/minute the speed of dripping apart from being 5cm, collect drop pill, drop is clean, puts the kerosene on drop pill surface on the skin, place natural drying, make 1000, promptly.
The embodiment hentriaconta-
Get pectin 26.5g, heat fused adds Radix Puerariae flavone 9.5g, fully stirs and makes its complete fusion, is uniformly dispersed, and puts in the surge drum of drop pill machine, and 90 ℃ are incubated 30 minutes, and surge drum water dropper gauge inner-diameter is 1.5 millimeters, and external diameter is 3.0 millimeters.Adjusting a distance is 6cm, the speed of dripping with 30 minutes splash at the uniform velocity that (temperature of condensed fluid top 30cm is 30 ± 2 ℃ in liquid Paraffin and methyl-silicone oil (1: 1) the condensation by mixing liquid, the temperature of bottom 35cm is 1 ± 1 ℃), collect drop pill, drop is clean, puts the kerosene on drop pill surface on the skin, places natural drying, make 1000, promptly.
Embodiment 32
Get xylitol and starch mixture 25.5g, 60～85 ℃ of heating and meltings add puerarin 9g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 60～85 ℃ of insulation systems of dripping, dropper mouth internal diameter is 1.2～2.5 millimeters, the difference of dropper mouth external diameter and internal diameter is less for well, the speed of dripping with 30 droplets/minute at the uniform velocity splashes in 0～18 ℃ of liquid Paraffin condensed fluid, collects drop pill, and drop is clean, put the paraffin on drop pill surface on the skin, place natural drying, make 1000, promptly.
Embodiment 33
Get lactose 20.4g, starch 4.1g, the two is fully mixed, and mixture is at 64 ℃ of heating and meltings, add puerarin 8g, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, system is dripped in 64 ℃ of insulations, and dropper mouth internal diameter is 1.2～2.5 millimeters, the difference of dropper mouth external diameter and internal diameter is less at the uniform velocity to splash in 0 ℃ of methyl-silicone oil condensed fluid with 40 droplets/minute the speed of dripping for well, collects drop pill, drop is clean, place natural drying, make 1000 drop pill, promptly.
Embodiment 34
Get the mixture of xylitol 20g and starch 5.5g,, add puerarin 7g at 60～70 ℃ of heating and meltings, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 62～66 ℃ of insulation systems of dripping, dropper mouth internal diameter is 1.2～2.5 millimeters, the difference of dropper mouth external diameter and internal diameter is less for well, the speed of dripping with 30 droplets/minute at the uniform velocity splashes in 0～8 ℃ of methyl-silicone oil, collects drop pill, and drop is clean, wipe the paraffin on drop pill surface away, place natural drying, make 1000, promptly.
Embodiment 35
Get the mixture of lactose 21.2g and starch 4.25g,, add puerarin 18g at 64～68 ℃ of heating and meltings, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 63～66 ℃ of insulation systems of dripping, dropper mouth internal diameter is 1.2～2.5 millimeters, the difference of dropper mouth external diameter and internal diameter is less for well, the speed of dripping with 40 droplets/minute at the uniform velocity splashes in 0 ℃ of methyl-silicone oil, collects drop pill, and drop is clean, wipe the paraffin on drop pill surface away, place natural drying, make 1000, promptly.
Embodiment 36
Get the mixture of lactose 12.5g and starch 4.5g,, add puerarin 11.0g at 64～68 ℃ of heating and meltings, fully stir and make its complete fusion, be uniformly dispersed, put in the surge drum of drop pill machine, 63～66 ℃ of insulation systems of dripping, dropper mouth internal diameter is 1.2～2.5 millimeters, the difference of dropper mouth external diameter and internal diameter is less for well, the speed of dripping with 40 droplets/minute at the uniform velocity splashes in 0～8 ℃ of methyl-silicone oil, collects drop pill, and drop is clean, wipe the paraffin on drop pill surface away, place natural drying, make 1000, promptly.
Embodiment 37
Get the mixture of xylitol 19.8g and starch 5.9g,, add puerarin 10.3g at 64～68 ℃ of heating and meltings, intact branch stirs and makes its complete fusion, is uniformly dispersed, and puts in the surge drum of drop pill machine, 63～66 ℃ of insulation systems of dripping, dropper mouth internal diameter is 1.2～2.5 millimeters, the difference of dropper mouth external diameter and internal diameter is less for well, the speed of dripping with 40 droplets/minute at the uniform velocity splashes in 0 ℃ of methyl-silicone oil, collects drop pill, and drop is clean, wipe the paraffin on drop pill surface away, place natural drying, make 1000, promptly.
Embodiment 38
(a) get puerarin 5.8g, xylitol 19.6g, starch 6.7g is standby;
(b) get xylitol and starch mix homogeneously, adding above-mentioned puerarin fully mixes, mixture stirs at 65 ℃ of heating and meltings, and mixing time is 10～30 minutes, insulation, at 65 ℃ of temperature following system, dropper bore is 1.2～2.5 millimeters, splashes in 0 ℃ the methyl-silicone oil, makes 1000 drop pill, with the drop pill drop to the greatest extent and wipe liquid coolant, promptly.
Embodiment 39
(a) get puerarin 2.0g, lactose 17.8g, starch 5.2g is standby;
(b) get lactose and starch mix homogeneously, adding above-mentioned puerarin fully mixes, mixture stirs at 85 ℃ of heating and meltings, and mixing time is 10～30 minutes, insulation, at 85 ℃ of temperature following system, dropper bore is 1.2～2.5 millimeters, splashes in 0 ℃ the methyl-silicone oil, makes 1000 drop pill, with the drop pill drop to the greatest extent and wipe liquid coolant, promptly.
Embodiment 40
(a) get puerarin 4.0g, xylitol 22.9g, arabic gum 7.1g is standby;
(b) get xylitol and arabic gum mix homogeneously, adding above-mentioned puerarin fully mixes, mixture stirs at 75 ℃ of heating and meltings, and mixing time is 10 minutes, insulation, at 75 ℃ of temperature following system, dropper bore is 1.2～2.5 millimeters, splashes in 0 ℃ the methyl-silicone oil, makes 1000 drop pill, with the drop pill drop to the greatest extent and wipe liquid coolant, promptly.
Embodiment 41
(a) get puerarin 1.5g, xylitol 28.0g, xanthan gum 2.0g is standby;
(b) get xylitol and xanthan gum mix homogeneously, adding above-mentioned puerarin fully mixes, mixture stirs at 70 ℃ of heating and meltings, and mixing time is 10～30 minutes, insulation, at 64 ℃ of temperature following system, dropper bore is 1.21～2.5 millimeters, splashes in 10 ℃ the vegetable oil, makes 1000 drop pill, with the drop pill drop to the greatest extent and wipe liquid coolant, promptly.
Embodiment 42
(a) get puerarin 2.5g, xylitol 16.5g, starch 7.0g is standby;
(b) get xylitol and starch mix homogeneously, add above-mentioned puerarin, mixture stirs at 110 ℃ of heating and meltings, and mixing time is 30 minutes, insulation, at 95 ℃ of temperature following system, dropper bore is 1.0～3.0 millimeters, splashes in 25 ℃ the vegetable oil, makes 1000 drop pill, with the drop pill drop to the greatest extent and wipe liquid coolant, promptly.
Claims (16)
1. drop pills of kudzuvine root, it is characterized in that it is to be made by puerarin or Radix Puerariae flavone, adjuvant, wherein adjuvant comprises filler and plasticity substrate, and filler adjuvant wherein is selected from the natural adjuvant of following one or more plant origins: sorbitol, lactose; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: starch, carboxymethyl starch, arabic gum, chitin, Furcellaran, Lac, sesbania gum, Ficus elastica, tragakanta, xanthan gum; Described drop pill is to obtain by following preparation method: add puerarin or Radix Puerariae flavone in above-mentioned appropriate amount of auxiliary materials, fully mix, the heating and melting temperature is 60～85 ℃, mixing time is 10～30 minutes, dripping the system temperature and be 60～85 ℃, dropper bore is 1.1～3.5 millimeters, condensing agent is 0～18 ℃ liquid paraffin or a methyl-silicone oil, with the drop pill drop to the greatest extent and wipe liquid coolant, and promptly.
2. drop pills of kudzuvine root as claimed in claim 1 is characterized in that wherein filler adjuvant is selected from following one or more the natural adjuvant of plant origin: lactose; Plasticity substrate wherein is selected from following one or more the natural adjuvant of plant origin: starch, arabic gum.
3. drop pills of kudzuvine root as claimed in claim 2 is characterized in that described adjuvant is lactose and starch, and lactose is 1: 0.2～1: 0.3 with the ratio of the weight of starch.
4. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that the adjuvant and the ratio of the weight of puerarin or Radix Puerariae flavone are 1: 0.1～1: 1.
5. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that the adjuvant and the ratio of the weight of puerarin or Radix Puerariae flavone are 1: 0.1～1: 0.6.
6. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that the adjuvant and the ratio of the weight of puerarin or Radix Puerariae flavone are 1: 0.2～1: 0.4.
7. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a lactose, and plasticizer is a chitin, and its filler is 1: 0.1 with the ratio of the weight of plasticizer.
8. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a sorbitol, and plasticizer is a Furcellaran, and its filler is 1: 0.2 with the ratio of the weight of plasticizer.
9. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a lactose, plasticizer carboxymethyl starch and Lac, and its filler is 1: 0.4 with the ratio of the weight of plasticizer.
10. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a lactose, and plasticizer is a sesbania gum, and its filler is 1: 0.2 with the ratio of the weight of plasticizer.
11. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a lactose, and plasticizer is Ficus elastica and tragakanta, and its filler is 1: 0.3 with the ratio of the weight of plasticizer.
12. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a lactose, and plasticizer is a Furcellaran, and its filler is 1: 0.4 with the ratio of the weight of plasticizer.
13. a kind of drop pills of kudzuvine root as claimed in claim 1 is characterized in that: described adjuvant filler is a lactose, and plasticizer is an xanthan gum, and its filler is 1: 0.5 with the ratio of the weight of plasticizer.
14. drop pills of kudzuvine root as claimed in claim 1, it is characterized in that: described drop pill is to prepare by following method: add puerarin or Radix Puerariae flavone in appropriate amount of auxiliary materials, fully mix, the heating and melting temperature is 64 ℃, dripping the system temperature and be 64 ℃, dropper bore is 1.2～2.5 millimeters, and condensing agent is 0 ℃ a methyl-silicone oil.
15. the preparation method of a drop pills of kudzuvine root comprises the steps:
(a) get puerarin or Radix Puerariae flavone, adjuvant is standby;
(b) in appropriate amount of auxiliary materials, add puerarin or Radix Puerariae flavone, fully mix, the mixture heated melt temperature is 60～85 ℃, mixing time is 10～30 minutes, dripping the system temperature and be 60～85 ℃, dropper bore is 1.1～3.5 millimeters, condensing agent is 0～18 ℃ liquid paraffin or a methyl-silicone oil, with the drop pill drop to the greatest extent and wipe liquid coolant, and promptly.
16. the preparation method of drop pills of kudzuvine root as claimed in claim 15 is characterized in that: the mixture heated melt temperature is 64 ℃, and dripping a system temperature and be 64 ℃, dropper bore is 1.2～2.5 millimeters, and condensing agent is 0 ℃ a methyl-silicone oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2005100136322A CN1872144B (en) | 2005-06-01 | 2005-06-01 | Drop pills of kudzuvine root, and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2005100136322A CN1872144B (en) | 2005-06-01 | 2005-06-01 | Drop pills of kudzuvine root, and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1872144A CN1872144A (en) | 2006-12-06 |
| CN1872144B true CN1872144B (en) | 2010-11-03 |
Family
ID=37482854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2005100136322A Expired - Fee Related CN1872144B (en) | 2005-06-01 | 2005-06-01 | Drop pills of kudzuvine root, and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1872144B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101569614B (en) * | 2009-06-08 | 2011-03-30 | 成都医学院 | A kind of puerarin-coated slow-release dropping pill and preparation method thereof |
-
2005
- 2005-06-01 CN CN2005100136322A patent/CN1872144B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 王巍.新基质复方丹参滴丸的研究.中国优秀博硕士学位论文全文数据库 (硕士) 医药卫生科技辑 2005年第1期.2005,(2005年第1期),7、11、12、22、24、62. |
| 王巍.新基质复方丹参滴丸的研究.中国优秀博硕士学位论文全文数据库 (硕士) 医药卫生科技辑 2005年第1期.2005,(2005年第1期),7、11、12、22、24、62. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1872144A (en) | 2006-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100421721C (en) | Medication for relieving cough and asthma | |
| CN1872144B (en) | Drop pills of kudzuvine root, and preparation method | |
| CN100450504C (en) | Medication for treating pharyngitis | |
| CN100455314C (en) | Medication for treating cough | |
| CN100563635C (en) | A kind of ageratum drop pill | |
| CN100502840C (en) | Medication for treating chronic rhinitis and nasal sinusitis | |
| CN1872191B (en) | Drop pills of 'Yixintong' and prepartion method | |
| CN100563634C (en) | A kind of Herba Sidae Rhombifoliae soup drop pill | |
| CN1872230B (en) | A medication for treating coronary heart disease and preparation method | |
| CN1872079B (en) | Drop pills for treating cardiovascular diseases and cerebrovascular disease, and preparation method | |
| CN1872099B (en) | Medication for treating cardiovascular diseases, and cerebrovascular disease | |
| CN100421684C (en) | Medication for treating coronary heart disease and angina | |
| CN1872232B (en) | Composition of medication for curing cerebrovascular disease, and preparation method | |
| CN1872161B (en) | Drop pills of Chaihuang, and preparation method | |
| CN1872074B (en) | Compound drop pills of 'Huangtangning', and preparation method | |
| CN1872111B (en) | Medication for treating cardiovascular diseases and cerebrovascular disease | |
| CN1872285B (en) | Drop pills of Chinese traditional medicine, and preparation method | |
| CN1872318B (en) | Drop pills of oil of zedoary turmeric, and preparation method | |
| CN1872250B (en) | Composition of medication for treating headache | |
| CN1872231B (en) | Drop pills for treating diabetes, and preparation method | |
| CN100450489C (en) | Huangyangning drop pills and preparation method | |
| CN100512824C (en) | Medication for treating headache | |
| CN1872044B (en) | Medication for treating coronary heart disease | |
| CN100553620C (en) | A kind of medicine for the treatment of the thoracic obstruction | |
| CN100536831C (en) | Medication for treating cardiovascular and cerebrovascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101103 Termination date: 20190601 |